References to biological effects are provided for scientific context only and must not be interpreted as claims of therapeutic, diagnostic, or clinical benefit
However, because clinical studies are very limited, the usefulness of statins to help treating LC cannot be definitively assessed
Overall, GLP-1 agonists present a novel but manageable profile of ED-relevant toxicities
So, a medicine that improves weight, blood sugar, blood pressure, and kidney or heart risk could be very important for some lupus patients
It is likely that Cigna would cover Wegovy for this use with a prior authorization, but its best to check with your specific plan to be sure
PubMed laboratory research record [PMID: 3380117] PubMed record related to this compound for laboratory literature review